热门资讯> 正文

Coya Therapeutics完成了研究者发起的开放标签研究的患者招募，该研究采用低剂量IL-2和CTLA 4-IG联合治疗轻度至中度额颞叶痴呆患者

2025-09-29 20:20

世纪电信(CTL) 0

Following the positive interim results in 5 patients announced earlier this year, a total of 9 patients have been enrolled as planned

The study is progressing according to protocol, and no safety issues have been reported

Study completion is anticipated in Q4 2025 with topline to follow

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。